Merck & Co., Inc. Debt Securities, Available-for-sale, Current
Merck & Co., Inc. (MRK) had Debt Securities, Available-for-sale, Current of $749.00 million as of 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2020-02-26
- 2019-12-31: Debt Securities, Available-for-sale, Current $749.00M.
- 2019-09-30: Debt Securities, Available-for-sale, Current $129.00M.
- 2019-06-30: Debt Securities, Available-for-sale, Current $398.00M.
- 2019-03-31: Debt Securities, Available-for-sale, Current $691.00M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2019-12-31 | $749.00M 10-K · filed 2020-02-26 |
| 2019-09-30 | $129.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $398.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $691.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $894.00M 10-K · filed 2019-02-27 |
| 2018-09-30 | $2.40B 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.30B 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.90B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.40B 10-K · filed 2018-02-27 |
| 2017-09-30 | $3.00B 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.20B 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.50B 10-Q · filed 2017-05-09 |
| 2016-12-31 | $7.80B 10-K · filed 2017-02-28 |
| 2016-09-30 | $5.20B 10-Q · filed 2016-11-07 |
| 2016-06-30 | $5.20B 10-Q · filed 2016-08-08 |
| 2016-03-31 | $3.20B 10-Q · filed 2016-05-09 |
| 2015-12-31 | $4.80B 10-K · filed 2016-02-26 |
| 2015-09-30 | $4.50B 10-Q · filed 2015-11-05 |
| 2015-06-30 | $4.30B 10-Q · filed 2015-08-06 |
| 2015-03-31 | $7.40B 10-Q · filed 2015-05-07 |
| 2014-12-31 | $8.30B 10-K · filed 2015-02-27 |
| 2014-09-30 | $3.00B 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.70B 10-Q · filed 2014-08-07 |
| 2014-03-31 | $4.70B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.90B 10-K · filed 2014-02-27 |
| 2013-09-30 | $4.10B 10-Q · filed 2013-11-07 |
| 2013-06-30 | $3.00B 10-Q · filed 2013-08-07 |
| 2013-03-31 | $3.00B 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.70B 10-K · filed 2013-02-28 |
| 2012-09-30 | $757.00M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $698.00M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $910.00M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.40B 10-K · filed 2012-02-28 |
| 2011-09-30 | $1.30B 10-Q · filed 2011-11-08 |
| 2011-06-30 | $1.60B 10-Q · filed 2011-08-08 |
| 2011-03-31 | $1.30B 10-Q · filed 2011-05-09 |
| 2010-12-31 | $1.30M 10-K · filed 2011-02-28 |
| 2010-09-30 | $800.00M 10-Q · filed 2010-11-08 |
| 2010-06-30 | $1.30B 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |